WILLIAM C. WELDON - 07 Aug 2025 Form 4 Insider Report for Heartflow, Inc. (HTFL)

Role
Director
Signature
/s/ Angela Ahmad, Attorney-in-Fact for William C. Weldon
Issuer symbol
HTFL
Transactions as of
07 Aug 2025
Net transactions value
$0
Form type
4
Filing time
11 Aug 2025, 21:01:30 UTC
Previous filing
21 Nov 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WELDON WILLIAM C Director C/O HEARTFLOW, INC., 331 E. EVELYN AVENUE, MOUNTAIN VIEW /s/ Angela Ahmad, Attorney-in-Fact for William C. Weldon 11 Aug 2025 0001189019

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HTFL Common Stock Conversion of derivative security +136,286 +242% 192,562 11 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HTFL Stock Option Award $0 +23,710 $0.000000 23,710 07 Aug 2025 Common Stock 23,710 $19.00 Direct F3
transaction HTFL Series D Preferred Stock Conversion of derivative security -83,442 -100% 0 11 Aug 2025 Common Stock 83,442 Direct F1
transaction HTFL Series F Preferred Stock Conversion of derivative security -25,160 -100% 0 11 Aug 2025 Common Stock 25,160 Direct F2
transaction HTFL Series F-1 Preferred Stock Conversion of derivative security -27,704 -100% 0 11 Aug 2025 Common Stock 27,704 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
F2 Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
F3 The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.